{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:54:56Z","timestamp":1777730096693,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinbiochem.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T02:18:43Z","timestamp":1665973123000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers"],"prefix":"10.1016","volume":"111","author":[{"given":"Ramazan","family":"Uzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Kardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Alt\u0131n-Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Eken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurhan","family":"Cucer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamiyet","family":"Donmez-Altuntas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinbiochem.2022.10.009_b0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0950-3536(97)80032-7","article-title":"Gaucher\u2019s disease: Molecular, genetic and enzymological aspects","volume":"10","author":"Grabowski","year":"1997","journal-title":"Baillieres. Clin. Haematol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.10.009_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.10.009_b0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"issue":"16","key":"10.1016\/j.clinbiochem.2022.10.009_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: Relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"issue":"March","key":"10.1016\/j.clinbiochem.2022.10.009_b0025","first-page":"1","article-title":"Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece","volume":"24","author":"Dimitriou","year":"2020","journal-title":"Mol. Genet. Metab. Reports"},{"issue":"11","key":"10.1016\/j.clinbiochem.2022.10.009_b0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.10.009_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00005-016-0421-y","article-title":"Activated and Memory T lymphocytes in children with Gaucher disease","volume":"65","author":"Zahran","year":"2017","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"20","key":"10.1016\/j.clinbiochem.2022.10.009_b0040","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1182\/blood-2011-10-386862","article-title":"Phenotype diversity in type 1 Gaucher disease: Discovering the genetic basis of Gaucher disease\/hematologic malignancy phenotype by individual genome analysis","volume":"119","author":"Lo","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.10.009_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.10.009_b0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cmet.2014.10.008","article-title":"DNA damage response and metabolic disease","volume":"20","author":"Shimizu","year":"2014","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.10.009_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.10.009_b0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","article-title":"Cytokinesis-block micronucleus cytome assay","volume":"2","author":"Fenech","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2022.10.009_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","article-title":"HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures","volume":"534","author":"Fenech","year":"2003","journal-title":"Mutat. Res. - Genet. Toxicol. Environ. Mutagen."},{"issue":"10","key":"10.1016\/j.clinbiochem.2022.10.009_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11101203","article-title":"Cytokinesis-block micronucleus cytome assay evolution into a more comprehensive method to measure chromosomal instability","volume":"11","author":"Fenech","year":"2020","journal-title":"Genes (Basel)"},{"issue":"29","key":"10.1016\/j.clinbiochem.2022.10.009_b0075","doi-asserted-by":"crossref","first-page":"44879","DOI":"10.18632\/oncotarget.9821","article-title":"Mitochondrial dysfunction and oxidative stress in aging and cancer","volume":"7","author":"Kudryavtseva","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.10.009_b0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s Disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.10.009_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6189-9","article-title":"Prognostic significance of 8-hydroxy-2\u2032-deoxyguanosine in solid tumors: A meta-analysis","volume":"19","author":"Qing","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2907281","article-title":"Increased Chromosomal and Oxidative DNA Damage in Patients with Multinodular Goiter and Their Association with Cancer","volume":"2017","author":"Donmez-Altuntas","year":"2017","journal-title":"Int. J. Endocrinol."},{"issue":"13","key":"10.1016\/j.clinbiochem.2022.10.009_b0095","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/1535370219871895","article-title":"Highlight article: therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients","volume":"244","author":"Donmez-Altuntas","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mrgentox.2014.06.006","article-title":"Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects","volume":"771","author":"Donmez-Altuntas","year":"2014","journal-title":"Mutat. Res. - Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.10.009_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2017.03.030","article-title":"Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy","volume":"486","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgmr.2015.05.001","article-title":"Oxidative stress parameters of Gaucher disease type I patients","volume":"4","author":"Mello","year":"2015","journal-title":"Mol. Genet. Metab. Reports"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.10.009_b0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1076029613489595","article-title":"Oxidative stress, trace elements, and circulating microparticles in patients with Gaucher disease before and after enzyme replacement therapy","volume":"21","author":"Zahran","year":"2015","journal-title":"Clin. Appl. Thromb."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2022.10.009_b0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2005.07.022","article-title":"Blood oxidative stress markers in Gaucher disease patients","volume":"364","author":"Roversi","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.10.009_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12011-019-01709-3","article-title":"Oxidative Stress Parameters, Trace Elements, and Lipid Profile in Iranian Patients with Gaucher Disease","volume":"193","author":"Mozafari","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"issue":"October","key":"10.1016\/j.clinbiochem.2022.10.009_b0135","article-title":"Patients with Gaucher disease display systemic oxidative stress dependent on therapy status","volume":"25","author":"Kartha","year":"2020","journal-title":"Mol. Genet. Metab. Reports"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2022.10.009_b0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2014.01.005","article-title":"Gaucher disease: Plasmalogen levels in relation to primary lipid abnormalities and oxidative stress","volume":"53","author":"Moraitou","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2015.04.012","article-title":"DNA damage in Fabry patients: An investigation of oxidative damage and repair","volume":"784\u2013785","author":"Biancini","year":"2015","journal-title":"Mutat. Res. \u2013 Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.clinbiochem.2022.10.009_b0150","doi-asserted-by":"crossref","unstructured":"A.R. Collins, The comet assay for DNA damage and repair: Principles, applications, and limitations, Appl. Biochem. Biotechnol. \u2013 Part B Mol. Biotechnol., 26 (3), 249\u2013261, 2004, 10.1385\/MB:26:3:249.","DOI":"10.1385\/MB:26:3:249"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.10.009_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2018-024251","article-title":"Population-based cohort of 500 patients with Gaucher disease in Israel","volume":"9","author":"Jaffe","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.10.009_b0160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms20040843","article-title":"Defective sphingolipids metabolism and tumor associated macrophages as the possible links between gaucher disease and blood cancer development","volume":"20","author":"W\u0105tek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.10.009_b0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevOncog.2013005814","article-title":"Gaucher\u2019s disease and cancer: A sphingolipid perspective","volume":"18","author":"Barth","year":"2013","journal-title":"Crit. Rev. Oncog."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.10.009_b0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: A model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit. Rev. Oncog."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:58:47Z","timestamp":1757865527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912022002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"alternative-id":["S0009912022002326"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.10.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}